Hongfei Zhou, PhD

Pharmacologist, Division of Bioequivalence III, OB, OGD, CDER

Dr. Zhou is a Senior Pharmacologist in the Division of Bioequivalence III (DBIII), Office of Bioequivalence (OB), Office of Generic Drugs (OGD), Center for Drugs Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA). Dr. Zhou received his Ph.D. in Toxicology from University of Colorado and has a diversified educational background in Computer Science and Microbiology. He joined the OGD in 2014 as a bioequivalence assessor and has been actively involved in multiple scientific and regulatory working groups either as a group lead or a team member. He is experienced in assessing the in vivo and in vitro bioequivalence of various dosage forms of complex generic drug products.

Early bird tickets
available now